COMPARISON OF PHENOTYPIC AND GENOTYPIC METHODS FOR DETECTION OF CARBAPENEM RESISTANCE IN AN INDIAN TERTIARY CARE HOSPITAL.

Crossref Cited-by Linking logo

  • Abstract
  • References
  • Cite This Article as
  • Corresponding Author

Background:-Carbapenem-resistant Enterobacteriaceae (CRE) are a family of bacteria that can result in deadly infections because they are resistant to most antibiotics.Minimum inhibitory concentrations( MICs) are important in diagnostic laboratories to confirm resistance of microorganisms to an antimicrobial agent and also to monitor the activity of new antimicrobial agents whileas polymerase chain reaction confirms the detection of a particular gene . Aims & objectives:- To compare the MIC obtained by microbroth dilution method (BMD) with PCR for detection of blaKPC gene of the recovered isolates of Klebsiella pneumoniae. Material & Methods:-This study was conducted in the Department of Microbiology, Sher-i-Kashmir Institute of Medical Sciences, Srinagar; over a period of one year and three months.It included all isolates of Klebsiella pneumoniae recovered from blood culture of the patients. The identification and antimicrobial susceptibility was done on Vitek 2. Isolates that were resistant to meropenem were included for Microbroth dilution method for MIC and Conventional Polymerase Chain Reaction for blakpc gene.Results:-Minimum Inhibitory Concentration (MIC) was done on 55 Meropenem resistant isolates by Broth Microdilution test. A total of 20(36.3%) isolates had MIC of ?256 µg/ml followed by 18(32.7%) isolates with a MIC of 128 µg/ml , followed by 11(20%) isolates with MIC of 64 µg/ml and 6(10.9%) isolates with MIC of 32 µg/ml . On comparison of MIC with PCR for blaKPC gene findings it was seen that out of 20 isolates with MIC ?256 , 18(90%) were positive for blaKPC gene , among isolates with MIC 128 µg/ml, 61% were positive for blaKPC gene . whereas isolates with MIC 64µg/ml 72.7% were positive for this gene and isolates with MIC 32 µg/ml, 66.7% were positive for the blaKPC gene.Conclusion: All the Klebsiella pneumoniae resistant isolates by vitek 2 were also having MIC in resistant range by BMD method and isolates positive for blaKPC gene are having higher MIC ranges.

  1. Fidelis E,Patricia C, Mark P B,Chad C and David R W .Comparison of Clinical & Laboratory Standards Institute standards in antimicrobial susceptibility among the carbapenemase producing Future Sci. OA (2017) 3(4), FSO245.
  2. Nordmann P and Poirel L. Emerging carbapenemases in Gram-negative aerobes. ClinMicrobiol Infect,2002 8(6), 321-331.
  3. Anne Marie Q , Karen B.Carbapenemases;the versatile beta lactamases.Clin.Microbiol. Rev. 2007( 20)3, 440-458.
  4. Paterson DL, Bonomo RA. Extended-spectrum beta-lactamases: a clinical update. Clinical Microbiology Reviews.2005; 18:657?686.
  5. Miriagou V, Tzouvelekis LS, Rossiter S,? Tzelepi E, Angulo FJ, Whichard JM et al. Imipenem resistance in a Salmonella clinical strain due to plasmid-mediated class A carbapenemase KPC-2.Antimicrob.Agents 47:1297?1300.
  6. Woodford N, Tierno PM, Young JK, Tysall L, Palepou MF,? Ward E et al. Outbreak of Klebsiella pneumoniae producing a new carbapenem-hydrolyzing class A lactamase, KPC-3, in a New York medical center. Antimicrob.Agents Chemother.48:4793?4799.
  7. Yigit H,Queenan AM,Rasheed JK,Biddle JW,Domenech-Sanchez A,Alberti S et al.Carbapenem-resistant strain of Klebsiella oxytoca harbouring carbapenem-hydrolyzing lactamase KPC-2.Antimicrob.Agents Chemother.47:3881?3889.
  8. Anderson KF,Lonsway DR,Rasheed JK,Biddle J,Jensen B,McDougal LK et al .Evaluation of methods to identify the Klebsiella pneumoniae carbapenemase in Enterobacteriaceae.Journal of Clinical Microbiology, Aug,2007,2723-2725.
  9. Mayer G. Antibiotics ? protein synthesis, nucleic acid synthesis, and metabolism. In: Immunol. Hunt RC (Ed.). University of South Carolina, SC, USA (2016). http://www.microbiologybook.org/mayer/antibiot.htm.
  10. Sievert DM, Ricks P, Edwards JR et al. Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009?2010. Control Hosp. Epidemiol.2013; 34(1), 1?14.
  11. Gupta N, Limbago BM, Patel JB, Kallen AJ. Carbapenem-resistant Enterobacteriaceae: Epidemiology and prevention. Infect.Dis. 2011; 53(1), 60?67.
  12. Clinical and Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility testing. 22nd informational supplement (M100-S22). Wayne, PA: CLSI; 2012.
  13. Clinical and Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility testing. 24nd informational supplement (M100-S24). Wayne, PA: CLSI; 2014.
  14. Schechner V, Straus-Robinson K,Schwartz D,Pfeffer I,Tarabeia J,Moskovich R et al .Evaluation of PCR-based testing for surveillance of KPC-producing Carbapenem resistant members of the Enterobacteriaceae family. Journal of Clinical Microbiology.Oct 2009;47(10):3261-3265.
  15. Marquez P,Terashita D, Dassey D, Mascola L.Population-based incidence of carbapenem-resistant Klebsiella pneumoniae along the continuum of care, Los Angeles County. Infect Control Hosp Epidemiol. 2013 Feb;34(2):144-50.
  16. Shanmugam P, Meenakshisundaram J,Jayaraman P.blaKPC gene Detection in Clinical Isolates of Carbapenem Resistant Enterobacteriaceae in a Tertiary Care Hospital.J Clin Diagn Res. 2013 Dec;7(12):2736-8.
  17. Seibert G ,H?rner R ,Meneghetti BH ,Righi RA ,Frasson NA ,Forno D et al .Nosocomial infections by Klebsiella pneumoniae carbapenemase producing enterobacteria in a teaching hospital Einstein (S?o Paulo) . International Journal of Basic and Applied Medical Sciences .2014;12(3):282-6.
  18. Parveen RM,Harish BN, Parija SC.Emerging Carbapenem Resistance Among Nosocomial Isolates Of Klebsiella Pneumoniae in South india.International Journal of Pharma and Bio Sciences V1(2)2010.
  19. Giani T, Pini B, Arena F, Conte V, Bracco S, Migliavacca R et al .Epidemic diffusion of KPC carbapenemase producing Klebsiella pneumoniae in Italy results of the first country wide survey 15th may to 30th june 2011.Euro Surveill.2013;18(22).
  20. Castenheira,Woosley LN,Mendes RE,Sader HS,Jones RN .Epidemiologic Detection of Carbapenemase-producing Klebsiella by EUCAST or CLSI Clinical Breakpoints ICAAC 2009. JMI Laboratories North Liberty, IA, USA.
  21. Endimiani A,Hujer AM, Perez F, Bethel CR, ? Hujer KM, Kroeger J et al.Characterization of blaKPC containing Klebsiella pneumoniae isolates detected in different institutions in the Eastern USA. J Antimicrob Chemother. 2009 Mar; 63(3): 427?437.
  22. Pournaras S, Kristo I, ?Vrioni G, ?Ikonomidis A, Poulou A, ?Petropoulou D,et al .Characteristics of Meropenem Heteroresistance in Klebsiella pneumoniae Carbapenemase (KPC)-Producing Clinical Isolates of pneumoniae..J. Clin. Microbiol. 2010; 48 (7) 2601-2604.

[Asifa Bhat1, Dalip K. Kakru1, Suhail Farooq2, Dekyong Angmo1, Mohmmad Suhail3, Shaista Nazir1, Shazia Benazir1 and Lenah Bashir1. (2018); COMPARISON OF PHENOTYPIC AND GENOTYPIC METHODS FOR DETECTION OF CARBAPENEM RESISTANCE IN AN INDIAN TERTIARY CARE HOSPITAL. Int. J. of Adv. Res. 6 (May). 1452-1457] (ISSN 2320-5407). www.journalijar.com

Asifa Bhat
Senior resident, Department Of Microbiology Skims Soura

DOI:

Article DOI: 10.21474/IJAR01/7178      
DOI URL: https://dx.doi.org/10.21474/IJAR01/7178

Download Full Paper

Download PDF No. of Downloads: 46 | No. of Views: 116